Stay updated on Pembrolizumab with BCG in HR NMIBC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with BCG in HR NMIBC Clinical Trial page.

Latest updates to the Pembrolizumab with BCG in HR NMIBC Clinical Trial page
- Check6 days agoChange DetectedThe page's revision marker was updated from v3.6.5 to v3.6.6, signaling a minor update to the page's version.SummaryDifference0.0%

- Check13 days agoChange Detected2018 ( U.S. NIH Grant/Contract ) was added to the study's funding information, indicating NIH support for the trial in 2018.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRevision: v3.6.5 has been added to the page, replacing the former v3.6.4 version. The Plain Language Summary section has been removed.SummaryDifference0.0%

- Check49 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, indicating a backend/content-management update.SummaryDifference0.0%

- Check70 days agoChange DetectedThe page's revision tag was updated from Revision: v3.6.0 to Revision: v3.6.3 to reflect a newer version.SummaryDifference0.0%

- Check77 days agoChange DetectedBolzano's location entry has been updated to Bolzano, Trentino-Alto Adige, Italy, 39100, replacing the previous Bolzano entry listed under Trentino-Sudtirol. This reflects a regional naming update and provides the same city/address in the study's locations.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab with BCG in HR NMIBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with BCG in HR NMIBC Clinical Trial page.